Article

ACA to Impact NH hospitals

Dartmouth-Hitchcock Medical Center and other New Hampshire hospitals may see an increase of patients and changes in healthcare approach as the Patient Protection and Affordable Care Act goes into effect in the coming months.

Dartmouth-Hitchcock Medical Center and other New Hampshire hospitals may see an increase of patients and changes in healthcare approach as the Patient Protection and Affordable Care Act goes into effect in the coming months.

Starting Tuesday, New Hampshire residents and small businesses will be able to compare and purchase state-approved health insurance plans through a federally operated health insurance exchange website. Those who buy plans through the exchange qualify for federal subsidies depending on their income and will have coverage beginning on Jan. 1. The enrollment period represents the first step toward the individual mandate of the Affordable Care Act, which requires most Americans to have health insurance or pay a penalty.

DHMC and other New Hampshire hospitals may face an initial surge of patients seeking treatment after Jan. 1, similar to what hospitals in Massachusetts experienced following the implementation of the state’s 2006 health care reform law, Geisel School of Medicine professor William Weeks said. The 2006 law mandated a minimum level of insurance for Massachusetts state residents.

Read the full story here: http://bit.ly/18tOUXX

Source: The Dartmouth

Related Videos
Dr Raymond Osarogiagbon
Richard J. Nowak, MD, MS, Yale School of Medicine
Naim Alkhouri, MD
Jaime Almandoz, MD, MBA
Martin Edelman, MD
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo